 Yet another study has come out recommending the class of medicines called GLP-1 agonists for type 2 diabetes. These medicines are already in the news to treat obesity, both in those with diabetes and those without, and more conditions that might benefit from them are under study. Rita Kalyani, a diabetes expert at Johns Hopkins, says the wealth of indications is striking.